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The regulation of human immunodeficiency virus type 1 infection and replication in primary monocytes was 
investigated by mutagenesis of recombinant proviral clones containing an env determinant required for the 
infectivity of monocytes. Virus replication was assayed by determination of reverse transcriptase activity in 
culture fluids and by recovery of virus from monocytes following cocultivation with uninfected peripheral blood 
mononuclear cells. Three virus replication phenotypes were observed in monocytes: productive infection, silent 
infection, and no infection. Incorporation of the monocytetropic env determinant in a full-length clone 
incapable of infection or replication in primary monocytes (no infection) conferred the capacity for highly 
efficient virus replication in monocytes (productive infection). Clones with the env determinant but lacking 
either functional vpr or vpu genes generated lower replication levels in monocytes. Mutation of both vpr and 
vpu, however, resulted in nearly complete attenuation of virus replication in monocytes, despite subsequent 
virus recovery from infected monocytes by cocultivation with uninfected peripheral blood mononuclear cells 
(silent infection). These findings indicate a central role for the "accessory" genes vpu and vpr in productive 
human immunodeficiency virus type 1 replication in monocytes and indicate that vpu and vpr may be capable 
of functional complementation. 
Human immunodeficiency virus type 1 (HIV-1) infection 
of macrophages has been demonstrated in brain, spinal cord, 
lung, lymph node, and skin during subclinical infection and 
disease and is postulated to underlie important clinical 
manifestations of HIV-1 infection, including disease latency 
and development of a spectrum of AIDS-related central 
nervous system disorders (2, 4, 11, 14, 15, 19, 33, 37). 
However, detailed molecular analysis of virus-host cell 
interactions involving monocytes was limited until recently 
by the restricted tropism of the earliest and most widely 
studied HIV-1 genetic clones for primary monocytes cul- 
tured in vitro (14, 15). Previously, we and others have 
demonstrated that a discrete env determinant, including the 
V3 loop but not the CD4-binding domain, is necessary and 
sufficient for HIV-1 infection of monocytes (23, 29, 36). 
Additionally, we have identified three virus replication phe- 
notypes in monocytes in vitro, using molecularly defined 
proviral clones (35). These include productive infection, 
with the generation of high virus replication levels; silent 
infection, with low to undetectable virus replication in 
monocytes, despite ultimate virus recovery from infected 
monocytes following cocultivation with uninfected, phyto- 
hemagglutinin-stimulated peripheral blood mononuclear 
cells (PBMCs [lymphoblasts]); and no infection, with neither 
virus replication in nor virus recovery from monocytes 
observed. In the present study, we investigated the roles of 
the HIV-1 "accessory" genes vpr and vpu, which are 
dispensable for virus replication in primary and immortal- 
ized CD4+ T lymphocytes. We demonstrate that vpr and vpu 
are central to the regulation of virus replication in primary 
* Corresponding author. 
monocytes and together mediate the expression of silent 
versus productive infection. 
To study viral regulation of monocyte infection, we uti- 
lized a panel of chimeric HIV-1 clones, constructed from the 
nonmonocytetropic clone HXB2 and the monocytetropic 
clone ADA, as previously described (16, 26, 35, 36). To 
correct a vpr defect in each of these clones, the result of a 
single base insertion in HXB2, 2.7-kb SalI-BamHI HXADA 
DNA fragments (nucleotides 5785 to 8474) were subcloned 
into the full-length proviral clone NL4-3, in which the vpr 
open reading frame is intact (1). The resultant NLHXADA 
clones contained the ADA-derived env determinant previ- 
ously localized to nucleotides 7040 to 7323, flanked by 
additional ADA- or HXB2-derived sequences encoding 
other portions of env and vpu and small portions of tat and 
rev. A clone in which the entire 5785-to-8474 sequence was 
HXB2 derived (thus lacking a monocytetropic env determi- 
nant) was used as a negative control for these experiments. 
Because HXB2 lacks a vpu initiator methionine codon, 
clones in which vpu was HXB2 derived were defective for 
that product, in contrast to clones with an ADA-encoded 
vpu. Finally, a vpr mutant corresponding to each NLHX- 
ADA clone was generated by introducing a frameshift mu- 
tation at codon 63. 
Virions from the recombinant clones, generated by trans- 
fection, were assayed for their ability to infect and replicate 
in primary monocytes by the presence of reverse tran- 
scriptase (RT) activity in culture supernatants (25) and by 
the ultimate recovery of virus following cocultivation of 
monocytes with uninfected PBMCs. The results are summa- 
rized in Fig. 1. All clones containing the ADA-derived env 
determinants and an intact vpr gene generated high virus 
replication levels in monocytes. Inactivation of vpr in these 
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FIG. 1. Replication of recombinant HIV-1 clones with both wild-type and mutant vpr genes. (A) The panel of recombinant NLHXADA 
clones is represented diagrammatically. The region of the genome corresponding to the HXADA fragments (nucleotides 5785 to 8474) is 
expanded to highlight the relative positions of HXBZ- and ADA-derived sequences. The open reading frames in this portion of the genome 
are represented above. Recombinant clones were generated by reciprocal DNA fragment exchanges of ADA- and HXB2-derived sequences 
into a SalI-BnrnHI fragment (5785 to 8474) from HXB2 subcloned into an intermediate shuttle vector, utilizing the restriction enzyme 
sites indicated on top. The resultant chimeric SalI-BamHI fragments were then subcloned into the clone NL4-3 to generate 
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clones, however, generated divergent results, depending 
upon the derivation of nucleotide sequences 5999 to 6345 
(SK fragment). Clones in which this portion of the genome 
was ADA derived generated lower (but readily detectable) 
virus replication levels than did their wild-type vpr counter- 
parts. However, vpr mutants in which SK was HXB2 
derived typically failed to generate virus replication levels 
detectable above background in monocytes, despite subse- 
quent virus recovery from these cultures onto uninfected 
PBMCs. The negative control clone, which carried a wild- 
type vpr but lacked the monocytetropic env determinant, 
generated virions which neither replicated in nor were 
recovered from monocytes, as previously demonstrated. No 
significant differences were seen in the replication of each 
virus strain on PBMCs obtained from several different 
donors. 
Monocytes were infected with recombinant HIV-1 clones 
containing a functional vpr gene, stained with toluidine blue, 
and examimed by light microscopy (1-km-thick plastic sec- 
tions). Cultures infected with a nonmonocytetropic virus, 
NLHXADA-SK, which contains a functional vpu gene, were 
indistinguishable from uninfected cells, with rare, small 
multinucleated cells (Fig. 2A). Cultures productively in- 
fected with virus containing the monocytetropic env deter- 
minant and a functional (NLHXADA-SM [Fig. 2B]) or 
nonfunctional (NLHXADA-GG [Fig. 2C]) vpu gene showed 
characteristic cytopathic effects (15). These consisted of the 
formation of multinucleated giant cells, often containing 10 
or more nuclei per cell, and cell lysis. The frequencies and 
sizes of these cells were comparable in the NLHXADA- 
SM- and NLHXADA-GG-infected monocyte cultures. Virus 
production and cellular degeneration and necrosis were 
primarily confined to the multinucleated cells. Transmission 
electron microscopy examination demonstrated typical bud- 
ding and mature virions in intracellular vacuoles that were 
associated with the plasma membrane, in both the presence 
and absence of vpu, but not in the NLHXADA-SK-infected 
cells (Fig. 2D). Freeze fracture scanning electron micros- 
copy demonstrated budding of virion particles from the 
plasma membrane of monocytes infected with virus which 
lacked a functional vpu (Fig. 2E). No virus could be detected 
in monocytes infected with recombinant clones lacking both 
vpr and vpu (data not shown). 
The SK fragment encodes the entire vpu gene product, 14 
amino acids at the C termini of both the tat and the rev first 
exons, and the N-terminal 41 amino acids of env (Fig. 3). 
Although the absence of a vpu initiator methionine codon in 
HXB2 is the most obvious difference between the SK 
portions of HXB2 and ADA, a role for tat ,  rev, or env could 
not be ruled out. The env sequences differ at 7 of 41 
predicted amino acid positions, not including the nonaligned 
insertion of 3 residues and deletion of 4 residues in ADA. All 
but three of these differences are confined to the signal 
peptide, which varies by up to 30% between different clones 
(20). Furthermore, tat and rev both differ at 3 of 14 amino 
acid positions between the ADA and HXB2 SK fragments, 
with four of these six changes being conservative in nature. 
Therefore, it is unlikely that these alterations in env, tat ,  or 
rev alter their function. However, to formally determine the 
specific requirement for vpu during HIV-1 infection of mono- 
cytes, the vpu initiator methionine codon of the silent 
infection clone NLHXADA-GG (vpr mutant) was restored 
by site-directed mutagenesis. The resultant clone was found 
to generate virus capable of productive infection of mono- 
cytes (data not shown). 
HIV-1 and related lentiviruses are distinct from most other 
retroviruses in that besides the structural gag ,  pol, and env 
genes common to all retroviruses, they also encode a num- 
ber of genes whose functions have been shown or are 
speculated to be regulatory in nature. In HIV-1, these genes 
include tat ,  rev, vif, nef, vpu, and vpr (6-8, 26, 32, 38). While 
tat ,  rev, and vif are essential for viral gene expression or 
virion infectivity, the precise role and overall importance of 
vpr, vpu, and nef are unclear, since these genes are dispens- 
able for virus infection and replication in CD4+ lymphocytes 
in vitro (8-10, 12, 13, 22, 24, 30, 32). The availability of 
molecular HIV-1 clones which infect and replicate in mono- 
cytes at levels comparable to those observed with many 
monocytetropic virus isolates has facilitated investigation of 
the role that these viral genes may play in regulating the 
virus life cycle in monocytes. In the present study, we 
observed moderately decreased levels of virus replication in 
the absence of either vpr or vpu, whereas in the absence of 
both genes, virus replication in monocytes dropped to levels 
barely at or below the level of detection by the RT assay, 
such that infection of these cells usually could be detected 
only by virus rescue onto PBMCs. 
The vpr open reading frame encodes a protein of 96 amino 
acids in most HIV-1 clones and is conserved in other 
lentiviruses, including visna-maedi virus (20, 31). Previous 
studies have shown that vpr is not required for HIV-1 
infection or replication in CD4+ lymphocytic cell lines in 
vitro, although its inactivation led to slower replication 
kinetics and delayed cytopathogenicity in these cells (6, 10, 
24). A recent study involving HIV type 2 (HIV-2) has shown 
that vpr is likewise dispensable during infection of PBMCs 
and T-cell lines but essential for productive infection of 
monocytes (17). The vpr protein has been demonstrated by 
radioimmunoprecipitation to be virion associated, and thus it 
is speculated to function either late in the virus life cycle, 
during particle assembly or maturation, or early, during the 
initial stages of infection (6). The vpu gene encodes an 80- 
to-82-amino-acid protein. It has not been reported whether 
the vpu protein is found in virion particles. vpu has been 
shown to augment virion particle release from infected cells 
without affecting levels of viral RNA or protein synthesis (8, 
32). In the absence of vpu, a higher ratio of immature to 
mature particles has been seen, with a shift in capsid 
recombinant NLHXADA clones. T o  inactivate vpr, clones were digested with EcoRI (nucleotide 5745), treated with Klenow fragment, and 
religated to  generate a 4-bp insertion, as  previously described (24). The replication levels of these clones in monocytes are summarized to the 
right of each clone. Monocytes were infected a s  previously described (36) by using filtered virus stocks generated by transfection of proviral 
DNA onto SW480 cell monolayers, and titers were determined by measuring RT activity. Infections were done at low multiplicities of 
infection (10 to  100 tissue culture infective doses per well) with monocytes plated at an initial density of 2 x lo5 cells per well. Virus replication 
was monitored by serial determinations of RT activity in culture supernatants (25). Peak RT activities (days 26 to  29) are expressed as lo5 
counts per minute per milliliter. T o  determine virus rescue, fresh, uninfected PBMCs were added to monocyte cultures at 29 days 
postinfection, cocultivated (co-cult) for 2 days, and maintained separately for up to 12 additional days, while RT activity was monitored. 
Rescue was scored a s  positive with two successive RT results that were more than fivefold above background level. ( B )  The replication 
kinetics of representative NLHXADA clones is graphed. Similar results were obtained in three to five replicate experiments. 
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FIG. 2. Light, transmission, and freeze fracture scanning electron microscopy of infected monocytes. Light micrographs of toluidine 
blue-stained semithin plastic sections showing typical fields of primary monocytes infected by nonmonocytetropic clone NLHXADA-SK (35) 
(A) and monocytetropic clones NLHXADA-SM (B)  and NLHXADA-GG (C) are shown (15). The multinucleated giant cells were fewer and 
smaller in panel A than in panels B and C. Magnification, ~ 4 8 0 .  Infected adherent cultured cells were carefully washed twice with 
phosphate-buffered saline (PBS), fixed in situ with 2% glutaraldehyde (pH 7.2) in PBS, scraped free with a rubber policeman, transferred to 
a 15-ml plastic conical tube, and pelleted for 10 min at 600 x g centrifugation. The cells were mixed with warm agar, repelleted in the 
Microfuge for 1 min, and refrigerated overnight to form a firm agar block. The cell block was divided into small pieces and processed into 
Spurr's plastic, after osmification and block uranyl acetate staining (15). Sections (1 km thick) were stained with toluidine blue for light 
microscopy, while thin sections (600 A [60.0 nm]) were stained with uranyl acetate and lead citrate for transmission electron microscopy. ( D )  
Transmission electron micrograph of a small portion of a multinucleated cell from NLHXADA-GG-infected monocytes showing a 
cytoplasmic vacuole (lower left) containing immature and mature virions and numerous typical mature particles associated with a stretch of 
plasma membrane. Magnification, ~ 3 4 , 0 0 0 .  (E)  Transmission electron microscopy view of NLHXADA-GG-infected monocytes, stabilized 
by formaldehyde fixation before quick-freezing, freeze-drying, and platinum replication (18). Budding from the convoluted surface are several 
50-nm-diameter brightly outlined spherical virus particles. At higher magnification (not shown), these display characteristic surface coats of 
gp120 "pegs." 
formation from the plasma membrane to intracellular mem- 
branes (8). In monocytes, however, particle assembly and 
release occur both at the plasma membrane and in intracel- 
lular vacuoles in the presence or absence of vpu, as shown in 
Fig. 2D. 
It is intriguing that HIV-2 and simian immunodeficiency 
virus lack a vpu open reading frame but instead carry a gene 
designated vpx, which encodes a protein of 114 to 118 amino 
acids in these viruses (20). vpu and vpx occupy similar 
positions in their respective viral genomes, between pol and 
env, but have only distant amino acid homology. Recently, it 
has been suggested that vpx and vpr arose by duplication 
from a common progenitor in HIV-2 and simian immunode- 
ficiency virus, on the basis of predicted amino acid sequence 
homology between the genes (34). T o  investigate the possi- 
bility of a similar link between vpr and vpu in HIV-1, the 
predicted amino acid sequences of both vpu and vpx were 
aligned with that of vpr (Fig. 4). Although less compelling 
that the homology between vpr and vpx, a 38% identity was 
observed between vpr and vpu over a 24-residue overlap at 
the C terminus of vpu and the N terminus of vpr. These 
sequences were particularly rich in acidic residues. Similar- 
ity in the hydrophilicity profiles of these portions of the vpu, 
vpr, and vpx products was also noted. The striking effect on 
virus replication levels in monocytes observed only when 
both genes were defective suggests that their gene products 
may perform similar roles and thus provide partial functional 




els were observed in the absence of either gene, the nearly 
complete attenuation observed in the absence of both may 
result from a compound effect of the loss of two relatively 
important but functionally unrelated genes. More detailed 
studies to determine the precise mechanisms of action of the 
vpr and \pic gene products will be required to address these 
alternatives. In either case, our data indicate that together, 
vpr and a second determinant, ~ p u ,  are more important for 
efficient HIV-1 infection and replication in primary mono- 
cytes than was observed previously in lymphocytes. These 
observations provide a rationale for designing potential 
antiviral therapies to block the action of these gene products 
during HIV-1 infection of monocytes. 
Persistent infection of tissue macrophages plays an impor- 
tant role in the pathogenic effects of other lentiviruses, 
including equine infectious anemia virus, visna-maedi virus, 
and caprine arthritis-encephalitis virus, providing a sanctu- 
ary for continuous virus replication in the face of a vigorous 
host immune response (15, 21). The onset of increased virus 
replication has been correlated with the onset of clinical 
disease manifestations, such as  encephalitis, pneumonitis, 
arthritis, and hemolytic anemia. Similarly, HIV-1 infection 
of macrophages generates a reservoir of virus which is 
present throughout the course of subclinical infection and 
clinical disease. The existence of poorly replieative HIV-1 
variants may be essential for establishment of persistent 
macrophage infection during the early, asymptomatic stage 
of disease. Several studies have suggested a relationship 
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FIG. 3. Comparison of S K  virus replication determinant from HXB2 and ADA. The predicted amino acid sequences o f  rplr and the 
portions of rat, re\,, and mr3 which are encoded by nucleotides 5909 to 6315 ( S K  fragment) from HXB2 and ADA are aligned by using 
single-letter amino acid designations. Identical residues are indicated within hoxes. 
3930 NOTES 
HIV1 Vpr 1 
FIG. 4. Predicted amino acid homology between vpr, vpu, and vpx. The predicted amino acid sequence of the NL4-3-derived vpr gene is 
aligned with homologous regions of the ADA-derived vpu gene and the vpx gene encoded by the HIV-2,,? clone, with single-letter amino 
acid designations. Identical residues are indicated within boxes. Hydrophilicity profiles for the correspond~ng segments of each protein are 
shown at the bottom. 
between the in vitro replicative properties of HIV-1 isolates 
in T lymphocytes and clinical-disease stage, with earlier 
isolates tending to replicate more slowly and to lower levels 
("slow, low") than isolates from later stages of disease 
("rapid, high") (3, 5 ,  27). Nonessential regulatory genes are 
ideally suited to act as "molecular switches" for control of 
replication phenotypes by their activation or inactivation, 
particularly in viruses such as HIV-1, which characteristi- 
cally generate high levels of sequence diversity. We demon- 
strate here that discrete genetic alterations in such accessory 
genes result in profoundly different replication rates in 
monocytcs in vitro, which suggests a mechanism for transi- 
tion from subclinical to clinical disease in vivo. These 
findings thus provide a rationale for addressing on a wider 
scale whether functional status of vpr and/or vpu correlates 
with disease stage or serves as a potential prognostic indi- 
cator of disease progression and outcome. 
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